Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.2435
-0.0065 (-2.60%)
Dec 17, 2025, 1:39 PM CET
-49.90%
Market Cap16.09M
Revenue (ttm)n/a
Net Income (ttm)-8.42M
Shares Out64.36M
EPS (ttm)-0.16
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume96,741
Average Volume438,735
Open0.2590
Previous Close0.2500
Day's Range0.2250 - 0.2590
52-Week Range0.1500 - 0.7000
Beta-0.19
RSI52.04
Earnings DateFeb 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.